Subscreva a nossa newsletter para se manter atualizado
Clique aqui
  • BLS

Safety guide: Asbestos

BLS Safety Guide: Asbestos


A guide written by Dr. Antonio Moffa, Dr. Claudia Beccaria and Lucrezia Giorgi of the Unit of Integrated Therapies in Otolaryngology at the University Polyclinic Campus Bio-Medical Foundation in Rome.

 

In the five-year period 2016-2020, an average of about 1,500 workers per year were recognised as having an asbestos-related disease. In the same years, around 50% of workers who contracted asbestos-related diseases suffered a permanent impairment of no more than 25%, while 37% of technopaths died as a result of the occupational disease. Specifically in 2016, the proportion of workers with an impairment of no more than 25 per cent remained almost unchanged, but those with a fatal outcome rose to 43 per cent.

The use of asbestos was banned in Italy in 1992 with Law No. 257, which set the terms and procedures for the cessation of all activities involving the processing and extraction of this mineral. After this date, the only permitted work activities involving exposure to asbestos are its clearance, removal and disposal.

The IARC (International Agency for Research on Cancer) has classified asbestos as a human carcinogen (Group 1).

The danger of asbestos derives from the degree of fibre freedom, i.e. the ability of asbestos-containing materials to release potentially inhalable fibres into the air. Since asbestos is a friable and fibrous material, it is easy for very small particles to be released into the air as a result of any type of stress (processing and handling, vibrations, infiltration of humidity), which, once inhaled, are capable of being deposited in the pulmonary alveoli, bronchi and pleura, causing irreversible tissue damage and the onset of pulmonary diseases. Moreover, as there is no risk threshold below which the concentration of asbestos fibres in the air is not dangerous, it follows that the inhalation of even a single fibre can cause fatal pathologies; clearly, prolonged exposure over time or to high quantities will exponentially increase the likelihood of contracting such pathologies.

The European Commission has recently approved an exposure limit value (or TLV) 10 times lower than the previous one (0.1 fibres/cm3), i.e. 0.01 fibres/cm3, for an 8-hour exposure reference. The harmful effects that occur following the inhalation of asbestos particles are derived from pathogenic mechanisms of an irritative, degenerative and carcinogenic nature and can lead to the onset of various diseases.

The pathologies resulting from breathing in asbestos fibres are all characterised by a long interval between the start of exposure and the appearance of the first symptoms of the disease: this interval, termed 'latency time', can generally last up to decades.

From these pathologies related to exposure to asbestos derives the importance of worker protection, which must be on several fronts: the worker must be equipped with personal respiratory protective equipment with an operational protection factor that ensures that the filtered air inside the PPE is no more than 1/10 of the limit value. The use of PPE must also be interspersed with rest periods appropriate to the physical effort required by the work, and the employer must carry out periodic measurements of the concentration of fibres in the air, reporting the results in the DVR (Risk Assessment Document).

 

 

Recommended products:

 

 

 

Stay informed
Stay safe.

 

Artigos relacionados

julho 9, 2021 BLS 8000next: the new ready-to-use half mask is now available

La nuova semimaschera con filtri incorporati BLS 8000next combina la semplicità dei dispositivi usa e getta con l’alto livello di protezione dei dispositivi riutilizzabili. É progettata per essere sostituita quando i filtri si esauriscono ed è eccellente contro particolato e gas. La forma dell'oronasale garantisce una tenuta ottimale, evitando punti di pressione sul viso dell’utente, […]

Link
março 2, 2022 March events | What's next

Eventi di marzo Scopri gli eventi BLS di Marzo   30 marzo - 01 aprile PESTMED 2022 La Fiera Evento per i professionisti del Pest Management e della Sanificazione in Italia, si terrà nella città di Bologna. Noi saremo lì, vieni a trovarci al padiglione 32, stand n. A27bis. Ti aspettiamo!   Questa fiera è […]

Link
maio 27, 2022 Donning Instructions | BLS Zer0

Sai indossare correttamente un DPI? Indossare un DPI nel modo corretto è fondamentale per trarne massima efficacia e migliori performance di prodotto.   Lo scopo della protezione respiratoria individuale è proteggere chi la indossa da sostanze tossiche o patogene diffuse per via aerea. Il suo utilizzo, quindi, dovrebbe essere preceduto da una formazione appropriata sulle […]

Link
Assine a newsletter
Receba atualizações sobre nossos eventos, notícias, catálogo e iniciativas futuras.
Inscreva-se

Contate-nos

Escreva-nos, responderemos em 48 horas.
Pedir informação

BLS S.R.L.
Società a Socio Unico
via dei Giovi, 41 - 20032 Cormano (MI) - Italia
t/f +39 02 39310212 / 66200473
info@blsgroup.it
Privacy Policy - Cookie Policy

Sede legal
via dei Giovi, 41 – 20032 Cormano (MI) - Italia
Capitale Sociale | Share Capital: Euro 600.000,00 i.v.
C.C.I.A.A. - R.E.A.: MI 1186898
Partita IVA | VAT N°: IT12296780153
C.F. e Iscrizione al Registro delle Imprese di Milano: 07822320151

BLS IBERIA / Av. Pau Casals, 8 08182 Sant Feliu de Codines Barcelona - Spain
BLS NORTHWEST / Reeweg, 132 3343 AP H.I. Ambacht Rotterdam - The Netherlands
BLS DO BRASIL / Rua Alvarenga Peixoto, 307 05095-010 Sao Paulo - SP - Brazil
BLS GERMANY / Dünner Straße 249 D-41066 Mönchengladbach - Germany
BLS FRANCE / 18 Porte du Grand Lyon 01700 Neyron - France

crossmenuchevron-downcross-circle